Sleeve Gastrectomy Reduces Hepatic Steatosis by Improving the Coordinated Regulation of Aquaglyceroporins in Adipose Tissue and Liver in Obese Rats

Obesity Surgery

Volumn 25, Issue 9, 2015, Pages 1723-1734

  Méndez Giménez, Leire ^a,b,c   Becerril, Sara ^a,b,c   Moncada, Rafael ^a,b,c   Valentí, Víctor ^a,b,c   Ramírez, Beatriz ^a,b,c   Lancha, Andoni ^a   Gurbindo, Javier ^a   Balaguer, Inmaculada ^a   Cienfuegos, Javier A ^a,b,c   Catalán, Victoria ^a,b,c   Fernández, Secundino ^a   Gómez Ambrosi, Javier ^a,b,c   Rodríguez, Amaia ^a,b,c   Frühbeck, Gema ^a,b,c  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Recinto de Complejo Hospitalario de Navarra   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

Aquaporins; Bariatric surgery; Fatty liver; Glycerol; Obesity

Indexed keywords

AQUAGLYCEROPORIN; AQUAPORIN 3; AQUAPORIN 7; AQUAPORIN 9; FATTY ACID; GHRELIN; GLYCEROL; INSULIN; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; AQP7 PROTEIN, RAT; AQUAPORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT DISTRIBUTION; BODY WEIGHT; CALORIC RESTRICTION; CELL COUNT; CELL SIZE; CONTROLLED STUDY; DIET INDUCED OBESITY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME REGULATION; FAT MASS; FATTY ACID BLOOD LEVEL; FATTY LIVER; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEROL BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER HYPERTROPHY; LIVER WEIGHT; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SLEEVE GASTRECTOMY; TISSUE LEVEL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; DISEASE MODEL; GASTRECTOMY; GENE EXPRESSION; GENETICS; LIVER; METABOLISM; OBESITY; OBESITY, MORBID; PHYSIOLOGY; PROCEDURES; WISTAR RAT;

ADIPOCYTES; ADIPOSE TISSUE; ADIPOSITY; ANIMALS; AQUAGLYCEROPORINS; AQUAPORINS; DISEASE MODELS, ANIMAL; FATTY LIVER; GASTRECTOMY; GENE EXPRESSION; LIVER; MALE; OBESITY, MORBID; RATS; RATS, WISTAR;

EID: 84938415675     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-015-1612-z     Document Type: Article

References (57)

1. King LS, Kozono D, Agre P. From structure to disease: the evolving tale of aquaporin biology. Nat Rev Mol Cell Biol. 2004;5:687–98.
2. Verkman AS, Anderson MO, Papadopoulos MC. Aquaporins: important but elusive drug targets. Nat Rev Drug Discov. 2014;13:259–77.
3. Frühbeck G. Obesity: aquaporin enters the picture. Nature. 2005;438:436–7.
4. Rodríguez A, Catalán V, Gómez-Ambrosi J, Frühbeck G. Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control. Cell Cycle. 2011;10:1548–56.
5. Reshef L, Olswang Y, Cassuto H, Blum B, Croniger CM, Kalhan SC, et al. Glyceroneogenesis and the triglyceride/fatty acid cycle. J Biol Chem. 2003;278:30413–6.
6. Hibuse T, Maeda N, Funahashi T, Yamamoto K, Nagasawa A, Mizunoya W, et al. Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. Proc Natl Acad Sci U S A. 2005;102:10993–8.
7. Hara-Chikuma M, Sohara E, Rai T, Ikawa M, Okabe M, Sasaki S, et al. Progressive adipocyte hypertrophy in aquaporin-7-deficient mice: adipocyte glycerol permeability as a novel regulator of fat accumulation. J Biol Chem. 2005;280:15493–6.
8. Rodríguez A, Catalán V, Gómez-Ambrosi J, García-Navarro S, Rotellar F, Valentí V, et al. Insulin- and leptin-mediated control of aquaglyceroporins in human adipocytes and hepatocytes is mediated via the PI3K/Akt/mTOR signaling cascade. J Clin Endocrinol Metab. 2011;96:E586–97.
9. Laforenza U, Scaffino MF, Gastaldi G. Aquaporin-10 represents an alternative pathway for glycerol efflux from human adipocytes. PLoS One. 2013;8:e54474.
10. Madeira A, Fernandez-Veledo S, Camps M, Zorzano A, Moura TF, Ceperuelo-Mallafré V, et al. Human aquaporin-11 is a water and glycerol channel and localizes in the vicinity of lipid droplets in human adipocytes. Obesity (Silver Spring). 2014;22:2010–7.
11. Kuriyama H, Shimomura I, Kishida K, Kondo H, Furuyama N, Nishizawa H, et al. Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. Diabetes. 2002;51:2915–21.
12. Rojek AM, Skowronski MT, Fuchtbauer EM, Fuchtbauer AC, Fenton RA, Agre P, et al. Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice. Proc Natl Acad Sci U S A. 2007;104:3609–14.
13. Ma T, Song Y, Yang B, Gillespie A, Carlson EJ, Epstein CJ, et al. Nephrogenic diabetes insipidus in mice lacking aquaporin-3 water channels. Proc Natl Acad Sci U S A. 2000;97:4386–91.
14. Calamita G, Gena P, Ferri D, Rosito A, Rojek A, Nielsen S, et al. Biophysical assessment of aquaporin-9 as principal facilitative pathway in mouse liver import of glucogenetic glycerol. Biol Cell. 2012;104:342–51.
15. Morinaga T, Nakakoshi M, Hirao A, Imai M, Ishibashi K. Mouse aquaporin 10 gene (AQP10) is a pseudogene. Biochem Biophys Res Commun. 2002;294:630–4.
16. Marrades MP, Milagro FI, Martínez JA, Moreno-Aliaga MJ. Differential expression of aquaporin 7 in adipose tissue of lean and obese high fat consumers. Biochem Biophys Res Commun. 2006;339:785–9.
17. Prudente S, Flex E, Morini E, Turchi F, Capponi D, De Cosmo S, et al. A functional variant of the adipocyte glycerol channel aquaporin 7 gene is associated with obesity and related metabolic abnormalities. Diabetes. 2007;56:1468–74.
18. Catalán V, Gómez-Ambrosi J, Pastor C, Rotellar F, Silva C, Rodríguez A, et al. Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver. Obes Surg. 2008;18:695–701.
19. Gena P, Mastrodonato M, Portincasa P, Fanelli E, Mentino D, Rodríguez A, et al. Liver glycerol permeability and aquaporin-9 are dysregulated in a murine model of non-alcoholic fatty liver disease. PLoS One. 2013;8:e78139.
20. Rodríguez A, Gena P, Méndez-Giménez L, Rosito A, Valentí V, Rotellar F, et al. Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease. Int J Obes. 2014;38:1213–20.
21. Wang C, Lv ZL, Kang YJ, Xiang TX, Wang PL, Jiang Z. Aquaporin-9 downregulation prevents steatosis in oleic acid-induced non-alcoholic fatty liver disease cell models. Int J Mol Med. 2013;32:1159–65.
22. Deitel M, Crosby RD, Gagner M. The first international consensus summit for sleeve gastrectomy (SG), New York City, October 25-27, 2007. Obes Surg. 2008;18:487–96.
23. Gagner M, Deitel M, Erickson AL, Crosby RD. Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obes Surg. 2013;23:2013–7.
24. de Bona CJ, Bettiol J, d'Acampora AJ, Castelan JV, de Souza JC, Bressiani V, et al. Sleeve gastrectomy model in Wistar rats. Obes Surg. 2007;17:957–61.
25. Valentí V, Martín M, Ramírez B, Gómez-Ambrosi J, Rodríguez A, Catalán V, et al. Sleeve gastrectomy induces weight loss in diet-induced obese rats even if high-fat feeding is continued. Obes Surg. 2011;21:1438–43.
26. Rodríguez A, Becerril S, Valentí V, Ramírez B, Martín M, Méndez-Giménez L, et al. Sleeve gastrectomy reduces blood pressure in obese (fa/fa) Zucker rats. Obes Surg. 2012;22:309–15.
27. Rodríguez A, Gómez-Ambrosi J, Catalán V, Gil MJ, Becerril S, Sáinz N, et al. Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes. 2009;33:541–52.
28. Kishida K, Shimomura I, Nishizawa H, Maeda N, Kuriyama H, Kondo H, et al. Enhancement of the aquaporin adipose gene expression by a peroxisome proliferator-activated receptor γ. J Biol Chem. 2001;276:48572–9.
29. Frühbeck G, Alonso R, Marzo F, Santidrián S. A modified method for the indirect quantitative analysis of phytate in foodstuffs. Anal Biochem. 1995;225:206–12.
30. Rodríguez A, Becerril S, Valentí V, Moncada R, Méndez-Giménez L, Ramírez B, et al. Short-term effects of sleeve gastrectomy and caloric restriction on blood pressure in diet-induced obese rats. Obes Surg. 2012;22:1481–90.
31. Muruzabal FJ, Frühbeck G, Gómez-Ambrosi J, Archanco M, Burrell MA. Immunocytochemical detection of leptin in non-mammalian vertebrate stomach. Gen Comp Endocrinol. 2002;128:149–52.
32. Frühbeck G, Gómez-Ambrosi J, Salvador J. Leptin-induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes. FASEB J. 2001;15:333–40.
33. Catalán V, Gómez-Ambrosi J, Rotellar F, Silva C, Gil MJ, Rodríguez A, et al. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus. Clin Endocrinol (Oxf). 2007;66:598–601.
34. Becerril S, Rodríguez A, Catalán V, Sainz N, Ramírez B, Collantes M, et al. Deletion of inducible nitric-oxide synthase in leptin-deficient mice improves brown adipose tissue function. PLoS One. 2010;5:e10962.
35. Skowronski MT, Lebeck J, Rojek A, Praetorius J, Fuchtbauer EM, Frokiaer J, et al. AQP7 is localized in capillaries of adipose tissue, cardiac and striated muscle: implications in glycerol metabolism. Am J Physiol Renal Physiol. 2007;292:F956–65.
36. Méndez-Giménez L, Rodríguez A, Balaguer I, Frühbeck G. Role of aquaglyceroporins and caveolins in energy and metabolic homeostasis. Mol Cell Endocrinol. 2014. doi:10.1016/j.mce.2014.06.017.
37. Frühbeck G, Toplak H, Woodward E, Yumuk V, Maislos M, Oppert JM. Executive Committee of the European Association for the Study of Obesity. Obesity: the gateway to ill health—an EASO position statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts. 2013;6:117–20.
38. Wilson-Perez HE, Chambers AP, Sandoval DA, Stefater MA, Woods SC, Benoit SC, et al. The effect of vertical sleeve gastrectomy on food choice in rats. Int J Obes. 2013;37:288–95.
39. Patrikakos P, Toutouzas KG, Perrea D, Menenakos E, Pantopoulou A, Thomopoulos T, et al. A surgical rat model of sleeve gastrectomy with staple technique: long-term weight loss results. Obes Surg. 2009;19:1586–90.
40. Stefater MA, Perez-Tilve D, Chambers AP, Wilson-Perez HE, Sandoval DA, Berger J, et al. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology. 2010;138:2426–36. 36 e1-3.
41. Lancha A, Moncada R, Valentí V, Rodríguez A, Catalán V, Becerril S, et al. Effect of sleeve gastrectomy on osteopontin circulating levels and expression in adipose tissue and liver in rats. Obes Surg. 2014;24:1702–8.
42. Frühbeck G, Díez Caballero A, Gil MJ. Fundus functionality and ghrelin concentrations after bariatric surgery. N Engl J Med. 2004;350:308–9.
43. Madeira A, Camps M, Zorzano A, Moura TF, Soveral G. Biophysical assessment of human aquaporin-7 as a water and glycerol channel in 3T3-L1 adipocytes. PLoS One. 2013;8:e83442.
44. Kishida K, Kuriyama H, Funahashi T, Shimomura I, Kihara S, Ouchi N, et al. Aquaporin adipose, a putative glycerol channel in adipocytes. J Biol Chem. 2000;275:20896–902.
45. Yasui H, Kubota M, Iguchi K, Usui S, Kiho T, Hirano K. Membrane trafficking of aquaporin 3 induced by epinephrine. Biochem Biophys Res Commun. 2008;373:613–7.
46. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and the American College of Gastroenterology. Gastroenterology. 2012;142:1592–609.
47. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40 Suppl 1:S5–10.
48. Dixon JB, Bhathal PS, O'Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg. 2006;16:1278–86.
49. Burza MA, Romeo S, Kotronen A, Svensson PA, Sjoholm K, Torgerson JS, et al. Long-term effect of bariatric surgery on liver enzymes in the Swedish obese subjects (SOS) study. PLoS One. 2013;8:e60495.
50. Wang Y, Liu J. Sleeve gastrectomy relieves steatohepatitis in high-fat-diet-induced obese rats. Obes Surg. 2009;19:921–5.
51. Kawano Y, Ohta M, Hirashita T, Masuda T, Inomata M, Kitano S. Effects of sleeve gastrectomy on lipid metabolism in an obese diabetic rat model. Obes Surg. 2013;23:1947–56.
52. Utzschneider KM, Kahn SE. Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2006;91:4753–61.
53. Kalhan SC, Mahajan S, Burkett E, Reshef L, Hanson RW. Glyceroneogenesis and the source of glycerol for hepatic triacylglycerol synthesis in humans. J Biol Chem. 2001;276:12928–31.
54. Jelen S, Wacker S, Aponte-Santamaria C, Skott M, Rojek A, Johanson U, et al. Aquaporin-9 protein is the primary route of hepatocyte glycerol uptake for glycerol gluconeogenesis in mice. J Biol Chem. 2011;286:44319–25.
55. Lebeck J. Metabolic impact of the glycerol channels AQP7 and AQP9 in adipose tissue and liver. J Mol Endocrinol. 2014;52:R165–78.
56. Elkjaer M, Vajda Z, Nejsum LN, Kwon T, Jensen UB, Amiry-Moghaddam M, et al. Immunolocalization of AQP9 in liver, epididymis, testis, spleen, and brain. Biochem Biophys Res Commun. 2000;276:1118–28.
57. Nicchia GP, Frigeri A, Nico B, Ribatti D, Svelto M. Tissue distribution and membrane localization of aquaporin-9 water channel: evidence for sex-linked differences in liver. J Histochem Cytochem. 2001;49:1547–56.